for treating chronic heart failure with reduced ejection fraction as per NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction THIS IS FOR DIABETES ONLY . Prescribe by brand (Victoza ® ) to avoid patients inadvertently receiving a different product licensed for obesity.

It should be swallowed whole with a sip of water (up to half a glass of water equivalent to 120 ml). Dispose of your lancets in a sharps container. If you are being treated with insulin, you can dispose of your lancets in the same sharps container you use for your insulin needles and syringes.Meal markers can be attached to tests to show which tests were pre-meal tests and which were post-meal tests.

You can use blood samples taken your fingertip, palm or forearm. A small sample of blood is required and your result is displayed in less than 5 seconds. Sanofi: Insuman (recombinant human insulin): permanent discontinuation of 3 presentations – end of supply in 2020 letter For your patients with diabetes who are currently prescribed Toujeo® SoloStar: A guide on how to use Toujeo ® SoloStar.MHRA: Canagliflozin (Invokana, Vokanamet): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients MHRA Alert: SGLT2 inhibitors: reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum) (Feb 2019) SLGT2 inhibitors are not to beused inprimary care for type 1 diabetes until further local guidance becomes available The CareSens N Blood Glucose Monitor offers easy and accurate testing and there’s no coding required. For your patients with diabetes who are currently prescribed Insuman® Basal: A step-by-step guide on how to use Insuman® Basal SoloStar.

For your patients with diabetes who are currently prescribed Toujeo® SoloStar: A video on how to use Toujeo® SoloStar. Pioglitazone should not be used in people who have heart failure or who are at higher risk of fracture. Continue Pioglitazone therapy only if there is a reduction of ≥0.5 percentage points in HbA1c in 6 months. Monitor for liver toxicity. There is risk of bladder cancer with pioglitazone. Do not use in active bladder cancer or a past history of bladder cancer, or in those who have uninvestigated macroscopic haematuria. Assess risks for bladder cancer after 3-6months of starting pioglitazone. Refer to current BNF for full contraindications and interactions Select a desired depth of one – to – seven (1-7) on the lancing device’s adjustable tip. Choose a depth by rotating the top portion of the adjustable tip until the setting number matches the arrow. Firmly insert a new lancet into the lancet holder. Hold the lancet firmly. Gently twist to pull off the protective disk. Save disk to recap lancet after use. Replace lancet device tip. Alogliptin is first choice DPP4- inhibitor. Alogliptin is licensed for use in type 2 diabetes as dual therapy in combination with either metformin, pioglitazone, a sulfonylurea, or insulin (when treatment with these drugs alone fails to achieve adequate glycaemic control); it is also licensed for use as triple therapy in combination with metformin and either pioglitazone or insulinTransfer to prescribing to Primary Care should not happen until specialists can demonstrate a reduction in nocturnal hypoglycaemia(e.g. after 3-4 months) The CareSens N meets and exceeds the 2013 ISO standards for blood glucose meter accuracy with 99% of results meeting the 2013 accuracy criteria. Sample loading – avoid spoiled tests For your patients with diabetes who are currently prescribed Apidra®: A guide on how to use Apidra®. Meter is restricted for use in people with needle phobia, paediatrics, visual impairments and physical impairments requiring single-handed use Insuman Comb 25 - Insuman® Comb 25 100 IU/mL- suspension for injection in a vial - Subcutaneous use.